Evidence map›Paper›PMID 20432439›Full record

ArticleJournal of cellular physiology2010

Constitutive activation of the mitogen-activated protein kinase pathway impairs vitamin D signaling in human prostate epithelial cells.

Zhentao Zhang, Pavlo Kovalenko, Min Cui, Marsha Desmet, Steven K Clinton, James C Fleet

Open access · greenAbstract read
In one paragraph

Article in Journal of cellular physiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Review
  3. Phosphorylation of RXRα mediates the effect of JNK to suppress hepatic FGF21 expression and promote metabolic syndrome.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  4. Review
  5. Review
  6. Article
  7. Vitamin D Signaling Suppresses Early Prostate Carcinogenesis in TgAPTCancer prevention research (Philadelphia, Pa.) · 2019
    Article
  8. Exploring vitamin D metabolism and function in cancer.Experimental & molecular medicine · 2018
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Cellular and molecular effects of vitamin D on carcinogenesis.Archives of biochemistry and biophysics · 2012
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Zhentao ZhangDepartment of Foods and Nutrition, Purdue University, West Lafayette, Indiana 47907-2059, USA.
Pavlo Kovalenko
Min Cui
Marsha Desmet
Steven K Clinton
James C Fleet
Purdue University West Lafayette · USThe Ohio State University · US

Funding

Vitamin D Status and Prostate CancerR01CA101113 · NCI · PURDUE UNIVERSITY WEST LAFAYETTE · PI FLEET, JAMES C. · 2004 to 2008
$1.9M
NCI NIH HHS CA101113NCI NIH HHS R01 CA101113
6 · The paper itself

Abstract

We studied the effect of prolonged activation of mitogen-activated protein kinase (MAPK) signaling on 1,25 dihydroxyvitamin D (1,25(OH)(2)D(3)) action in the immortalized human prostate epithelial cell line RWPE1 and its Ki-Ras transformed clone RWPE2. 1,25(OH)(2)D(3)-treatment caused growth arrest and induced gene expression in both cell lines but the response was blunted in RWPE2 cells. Vitamin D receptor (VDR) levels were lower in RWPE2 cells but VDR over-expression did not increase vitamin-D-mediated gene transcription in either cell line. In contrast, MAPK inhibition restored normal vitamin D transcriptional responses in RWPE2 cells and MAPK activation with constitutively active MEK1R4F reduced vitamin-D-regulated transcription in RWPE1 cells. 1,25(OH)(2)D(3)-mediated transcription depends upon the VDR and its heterodimeric partner the retinoid X receptor (RXR) so we studied whether changes in the VDR-RXR transcription complex occur in response to MAPK activation. Mutation of putative phosphorylation sites in the activation function 1 (AF-1) domain (S32A, T82A) of RXRalpha restored 1,25(OH)(2)D(3)-mediated transactivation in RWPE2 cells. Mammalian two-hybrid and co-immunoprecipitation assays revealed a vitamin-D-independent interaction between steroid receptor co-activator-1 (SRC-1) and RXRalpha that was reduced by MAPK activation and was restored in RWPE2 cells by mutating S32 and T82 in the RXRalpha AF-1 domain. Our data show that a common contributor to cancer development, prolonged activation of MAPK signaling, impairs 1,25(OH)(2)D(3)-mediated transcription in prostate epithelial cells. This is due in part to the phosphorylation of critical amino acids in the RXRalpha AF-1 domain and impaired co-activator recruitment.

Indexed as

Amino Acid SequenceCalcitriolCell LineCell Line, TransformedCell ProliferationEnzyme ActivationEpithelial CellsHumansMaleMAP Kinase Signaling SystemMitogen-Activated Protein KinasesModels, BiologicalMolecular Sequence DataNuclear Receptor Coactivator 1Oncogene Protein p21(ras)PhosphorylationCalcitriolMitogen-Activated Protein KinasesNuclear Receptor Coactivator 1Oncogene Protein p21(ras)Receptors, CalcitriolRetinoid X Receptor alpha

Identifiers

PMID20432439
PMCPMC2916698
OpenAlexW2054757357

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.